Microbial secondary metabolites as potential reserve of pharmaceuticals
The major characteristics of new bioactive microbial secondary metabolites are summarized in the review. A wide range of new molecular targets are implicated in discovery of new nonantibiotic compounds with some other pharmacological activities (noninfectious diseases). Microorganisms represent fascinating resources due to their production of novel products with broad spectra of bioactivities.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2014 |
|---|---|
| Erschienen: |
2014 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic - 59(2014), 3-4 vom: 28., Seite 38-44 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
Orlova, T I [VerfasserIn] |
|---|
| Themen: |
Anti-Bacterial Agents |
|---|
| Anmerkungen: |
Date Completed 30.10.2014 Date Revised 20.10.2016 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM242637612 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM242637612 | ||
| 003 | DE-627 | ||
| 005 | 20231224130827.0 | ||
| 007 | tu | ||
| 008 | 231224s2014 xx ||||| 00| ||rus c | ||
| 028 | 5 | 2 | |a pubmed24n0808.xml |
| 035 | |a (DE-627)NLM242637612 | ||
| 035 | |a (NLM)25300120 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Orlova, T I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Microbial secondary metabolites as potential reserve of pharmaceuticals |
| 264 | 1 | |c 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 30.10.2014 | ||
| 500 | |a Date Revised 20.10.2016 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a The major characteristics of new bioactive microbial secondary metabolites are summarized in the review. A wide range of new molecular targets are implicated in discovery of new nonantibiotic compounds with some other pharmacological activities (noninfectious diseases). Microorganisms represent fascinating resources due to their production of novel products with broad spectra of bioactivities | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Antiviral Agents |2 NLM | |
| 650 | 7 | |a Biological Factors |2 NLM | |
| 650 | 7 | |a Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Hypolipidemic Agents |2 NLM | |
| 700 | 1 | |a Bulgakova, V G |e verfasserin |4 aut | |
| 700 | 1 | |a Polin, A N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic |d 1988 |g 59(2014), 3-4 vom: 28., Seite 38-44 |w (DE-627)NLM012611506 |x 0235-2990 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2014 |g number:3-4 |g day:28 |g pages:38-44 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2014 |e 3-4 |b 28 |h 38-44 | ||